Denali Advisors’s Protalix BioTherapeutics PLX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-94,700	Closed	-$169K	–	489
2023 Q4	$169K	Sell	94,700 -15,500	-14%	-$27.6K	0.05%	239
2023 Q3	$183K	Hold	110,200	–	–	0.06%	234
2023 Q2	$220K	Buy	+110,200	New	+$220K	0.08%	208